We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
-2.82%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$415M
AUM Growth
-$275M
(-40%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-61.73%
Top 10 Holdings %
Top 10 Hldgs %
38.46%
Holding
421
New
30
Increased
6
Reduced
240
Closed
144
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MPLX
MPLX
|
+$1.61M |
| 2 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
+$1.43M |
| 3 |
Plains All American Pipeline
PAA
|
+$1.42M |
| 4 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$641K |
| 5 |
ECOM
CHANNELADVISOR CORPORATION
ECOM
|
+$573K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Castle Biosciences
CSTL
|
+$2.4M |
| 2 |
Century Communities
CCS
|
+$2.23M |
| 3 |
MasterCraft Boat Holdings
MCFT
|
+$2.18M |
| 4 |
CareCloud
CCLD
|
+$2.16M |
| 5 |
Fulgent Genetics
FLGT
|
+$2.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 45.53% |
| 2 | Healthcare | 9.95% |
| 3 | Consumer Staples | 8.81% |
| 4 | Industrials | 8.59% |
| 5 | Technology | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Starbucks
SBUX
$119B
| $2.92M | 0.7% |
33,981
-7,669
| -18% | -$612K |
|
27
Medtronic
MDT
$107B
| $2.88M | 0.7% |
27,747
-7,253
| -21% | -$728K |
|
28
Verizon
VZ
$182B
| $2.87M | 0.69% |
48,187
-11,335
| -19% | -$659K |
|
29
Honeywell
HON
$71.7B
| $2.85M | 0.69% |
18,337
-4,396
| -19% | -$653K |
|
30
Johnson & Johnson
JNJ
$599B
| $2.84M | 0.68% |
19,078
-6,018
| -24% | -$890K |
|
31
Pfizer
PFE
$141B
| $2.82M | 0.68% |
81,088
-21,895
| -21% | -$768K |
|
32
Merck
MRK
$307B
| $2.8M | 0.67% |
35,353
-8,154
| -19% | -$639K |
|
33
Coca-Cola
KO
$353B
| $2.79M | 0.67% |
56,560
-15,830
| -22% | -$761K |
|
34
Eli Lilly
LLY
$1.02T
| $2.79M | 0.67% |
18,816
-4,574
| -20% | -$708K |
|
35
Bristol-Myers Squibb
BMY
$123B
| $2.74M | 0.66% |
45,480
-10,347
| -19% | -$623K |
|
36
Philip Morris
PM
$300B
| $2.71M | 0.65% |
36,109
-9,180
| -20% | -$708K |
|
37
3M
MMM
$83B
| $2.67M | 0.64% |
19,930
-4,710
| -19% | -$634K |
|
38
AbbVie
ABBV
$448B
| $2.58M | 0.62% |
29,438
-7,282
| -20% | -$686K |
|
39
Altria Group
MO
$125B
| $2.53M | 0.61% |
65,590
-16,447
| -20% | -$684K |
|
40
IBM
IBM
$200B
| $2.52M | 0.61% |
21,657
-5,129
| -19% | -$604K |
|
41
Lockheed Martin
LMT
$117B
| $2.43M | 0.59% |
6,340
-1,517
| -19% | -$579K |
|
42
AT&T
T
$153B
| $2.41M | 0.58% |
112,073
-26,427
| -19% | -$591K |
|
43
JPMorgan Chase
JPM
$901B
| $2.38M | 0.57% |
24,740
-5,923
| -19% | -$582K |
|
44
Bank of America
BAC
$424B
| $2.38M | 0.57% |
98,639
-22,790
| -19% | -$567K |
|
45
Mondelez International
MDLZ
$77.4B
| $2.37M | 0.57% |
41,257
-9,037
| -18% | -$503K |
|
46
Caterpillar
CAT
$398B
| $2.35M | 0.57% |
15,765
-3,815
| -19% | -$536K |
|
47
Cisco
CSCO
$436B
| $2.32M | 0.56% |
58,825
-15,184
| -21% | -$662K |
|
48
Infosys
INFY
$45.8B
| $2.31M | 0.56% |
167,252
-3,165
| -2% | -$39.5K |
|
49
Intel
INTC
$488B
| $2.29M | 0.55% |
44,166
-13,059
| -23% | -$679K |
|
50
Target
TGT
$63.4B
| $2.27M | 0.55% |
14,407
-3,749
| -21% | -$514K |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Cadence Capital Management held 421 positions worth $415M, down 40% from $689M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Cadence Capital Management withdrew a net $256M in Q3 2020, closing 144 positions and reducing 240 holdings. Its most notable exit was MasterCraft Boat Holdings, an estimated $2.18M position sold in full.
By sector, the portfolio is most concentrated in Energy at 46% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Cadence Capital Management opened a new position in Meridian Bioscience Inc worth $560K.
- Cadence Capital Management's largest Q3 2020 buy was Meridian Bioscience Inc: 33,000 shares worth $560K.
- Cadence Capital Management added most to MPLX in Q3 2020, an estimated $1.61M increase.
- Cadence Capital Management's biggest Q3 2020 reduction was Castle Biosciences, cutting an estimated $2.4M.
- Cadence Capital Management fully exited MasterCraft Boat Holdings in Q3 2020, selling an estimated $2.18M.
- Cadence Capital Management's ten largest holdings make up 38% of its $415M portfolio in Q3 2020.
- Cadence Capital Management opened 30 new positions and closed 144 in Q3 2020.
- Cadence Capital Management's portfolio value fell 40% quarter-over-quarter to $415M.
Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.